Impact of TP53 alterations on outcomes in pediatric and young adult patients with relapsed / refractory B-cell acute lymphoblastic leukemia after CD19-CAR T-Cell therapy. - Alonso-Saladrigues A; Esperanza-Cebollada E; Vicente-Garcés C; Perez-Jaume S; Sánchez-Sierra N; Richarte-Franqués M; Català A; Crespo-Carrasco A; Dapena JL; Cuatrecasas Capdevila E; Faura Morros A; Ruiz-Cobo MA; et al. (Bone marrow transplantation, 2026)